I Jacques1, J Derelle, M Weber, M Vidailhet. 1. Service de Médecine Infantile 1 et 3, Hôpital d'Enfants, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre, France.
Abstract
UNLABELLED: We analysed the pulmonary evolution (radiological scores and pulmonary function) of 81 cystic fibrosis (CF) patients colonized by Pseudomonas aeruginosa (PA), by Burkholderia cepacia (BC) or by both these bacteria, compared to a control group. Pulmonary function was compared in the age bracket 6-13 years. Functional vital capacity (FVC) and forced expiratory volume (FEV1) values for PA colonized patients were significantly worse than for the control group but better than for children colonized by both organisms. In this last group, the evolution of radiological scores and pulmonary function showed a greater decline 2 years after the first colonization compared to the other groups. FVC and FEV1 values in patients colonized by BC were not worse than these of patients colonized by PA. Moreover, BC affected older patients with advanced lung disease and often previously colonized with PA. These results suggested that co-colonization by PA and BC could be a more deleterious factor on the pulmonary evolution than the isolated colonization by PA or BC, and that BC could be a severity marker rather than a cause. In addition, after starting the utilization of mouthpieces with filter at single use for spirometry in 1993 (without any other change in preventive measures already taken during hospitalization), incidence of BC decreased from 8.2% to zero, and no new case of BC colonization has been observed over the last 4 years. CONCLUSION: Co-colonization of CF patients by PA and BC is more deleterious for pulmonary evolution than colonization by one of these bacteria alone. Re-inforcement of environmental measures during hospitalization (e.g. use of disposable mouthpieces for spirometry) was sufficient to reduce the transmission of BC.
UNLABELLED: We analysed the pulmonary evolution (radiological scores and pulmonary function) of 81 cystic fibrosis (CF) patients colonized by Pseudomonas aeruginosa (PA), by Burkholderia cepacia (BC) or by both these bacteria, compared to a control group. Pulmonary function was compared in the age bracket 6-13 years. Functional vital capacity (FVC) and forced expiratory volume (FEV1) values for PA colonized patients were significantly worse than for the control group but better than for children colonized by both organisms. In this last group, the evolution of radiological scores and pulmonary function showed a greater decline 2 years after the first colonization compared to the other groups. FVC and FEV1 values in patients colonized by BC were not worse than these of patients colonized by PA. Moreover, BC affected older patients with advanced lung disease and often previously colonized with PA. These results suggested that co-colonization by PA and BC could be a more deleterious factor on the pulmonary evolution than the isolated colonization by PA or BC, and that BC could be a severity marker rather than a cause. In addition, after starting the utilization of mouthpieces with filter at single use for spirometry in 1993 (without any other change in preventive measures already taken during hospitalization), incidence of BC decreased from 8.2% to zero, and no new case of BC colonization has been observed over the last 4 years. CONCLUSION: Co-colonization of CF patients by PA and BC is more deleterious for pulmonary evolution than colonization by one of these bacteria alone. Re-inforcement of environmental measures during hospitalization (e.g. use of disposable mouthpieces for spirometry) was sufficient to reduce the transmission of BC.
Authors: J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb Journal: Lancet Date: 1993-07-03 Impact factor: 79.321
Authors: E H Bingen; M Weber; J Derelle; N Brahimi; N Y Lambert-Zechovsky; M Vidailhet; J Navarro; J Elion Journal: J Clin Microbiol Date: 1993-10 Impact factor: 5.948
Authors: L Sun; R Z Jiang; S Steinbach; A Holmes; C Campanelli; J Forstner; U Sajjan; Y Tan; M Riley; R Goldstein Journal: Nat Med Date: 1995-07 Impact factor: 53.440
Authors: O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason Journal: J Pediatr Date: 1985-09 Impact factor: 4.406
Authors: A Abdul Wahab; S J Taj-Aldeen; F Hagen; S Diophode; A Saadoon; J F Meis; C H Klaassen Journal: Eur J Clin Microbiol Infect Dis Date: 2013-09-01 Impact factor: 3.267
Authors: María I Morosini; María García-Castillo; Elena Loza; María Pérez-Vázquez; Fernando Baquero; Rafael Cantón Journal: J Clin Microbiol Date: 2005-09 Impact factor: 5.948
Authors: Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff Journal: Clin Microbiol Rev Date: 2012-01 Impact factor: 26.132
Authors: Steve P Bernier; Matthew L Workentine; Xiang Li; Nathan A Magarvey; George A O'Toole; Michael G Surette Journal: Front Microbiol Date: 2016-05-18 Impact factor: 5.640
Authors: Jan C Thomassen; Tobias Trojan; Maxine Walz; Christina Vohlen; Gregor Fink; Ernst Rietschel; Miguel A Alejandre Alcazar; Silke van Koningsbruggen-Rietschel Journal: ERJ Open Res Date: 2021-07-19